ストックスクリーナーアプリを入手
121.86
0.16%
0.20
アフターアワーズ：
122.00
0.14
+0.11%
前日終値:
$121.66
開ける：
$121.4
24時間の取引高:
8.66M
Relative Volume:
0.61
時価総額：
$302.46B
収益：
$65.00B
当期純損益:
$18.26B
株価収益率:
16.75
EPS:
7.2751
ネットキャッシュフロー:
$13.05B
1週間 パフォーマンス:
+2.20%
1か月 パフォーマンス:
+11.97%
6か月 パフォーマンス:
+43.48%
1年 パフォーマンス:
+42.36%
1日の値動き範囲:
$120.50
$122.60
1週間の範囲:
$120.39
$123.33
52週間の値動き範囲:
$73.31
$123.33
Merck Co Inc Stock (MRK) Company Profile
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
121.86 | 301.96B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,023.22 | 962.75B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
246.91 | 590.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
224.35 | 404.24B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
208.62 | 323.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
163.92 | 315.57B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-13 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-10-13 | 再開されました | Citigroup | Neutral |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Neutral |
| 2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-08 | ダウングレード | Truist | Buy → Hold |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
| 2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | アップグレード | UBS | Neutral → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Hold |
| 2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
| 2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 開始されました | Jefferies | Buy |
| 2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-14 | アップグレード | Berenberg | Hold → Buy |
| 2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | Goldman | Buy |
| 2021-12-16 | 開始されました | Daiwa Securities | Neutral |
| 2021-12-13 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-01 | アップグレード | Argus | Hold → Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-05-20 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-08-03 | アップグレード | Goldman | Neutral → Buy |
| 2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-16 | 開始されました | SVB Leerink | Outperform |
| 2019-07-03 | 開始されました | Mizuho | Buy |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 繰り返されました | Citigroup | Buy |
| 2018-10-09 | 再開されました | Guggenheim | Buy |
| 2018-04-23 | アップグレード | Goldman | Neutral → Buy |
| 2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
Where is Merck & Co., Inc. (MRK) Headed According to the Street? - Finviz
King Luther Capital Management Corp Sells 263,609 Shares of Merck & Co., Inc. $MRK - MarketBeat
Burling Wealth Partners LLC Sells 9,333 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use - Benzinga
First National Bank of Omaha Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck reports positive phase 3 second-season RSV data for ENFLONSIA (MRK:NYSE) - Seeking Alpha
FinancialContentMerck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons - FinancialContent
Merck & Co. Inc. (NYSE:MRK) Emerges as a Strong Dividend Contender Through Methodical Screening - ChartMill
Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug DiscoveryMerck & Co (NYSE:MRK) - Benzinga
Merck & Co. (MRK) Advances on Robust Keytruda Sales and Positive Clinical Trial Results - Insider Monkey
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine - Mayo Clinic News Network
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck and Mayo Clinic Announce AI Collaboration Agreement - Intellectia AI
Short Interest in Merck & Co., Inc. (NYSE:MRK) Decreases By 14.6% - MarketBeat
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell - marketscreener.com
Merck & Co., Inc. $MRK Shares Purchased by NEOS Investment Management LLC - MarketBeat
GSA Capital Partners LLP Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Mondrian Investment Partners LTD Invests $138.34 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lessened by Skandinaviska Enskilda Banken AB publ - MarketBeat
Merit Financial Group LLC Purchases 16,545 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Bancorp - MarketBeat
Texas Yale Capital Corp. Has $4.83 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Vanguard Group Inc. Sells 777,516 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Tobam - MarketBeat
M&G PLC Has $30.49 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Pallas Capital Advisors LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Assetmark Inc. Purchases 22,483 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Shell Asset Management Co. - MarketBeat
PNC Financial Services Group Inc. Purchases 144,703 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Calton & Associates Inc. - MarketBeat
Hardy Reed LLC Sells 8,831 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by HighTower Advisors LLC - MarketBeat
Aberdeen Group plc Sells 46,708 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN Amro Investment Solutions - MarketBeat
Merck stock price hits a 52-week high on Deutsche Bank upgrade as MRK heads into holiday week - TechStock²
Merck & Co., Inc. $MRK Shares Sold by Public Sector Pension Investment Board - MarketBeat
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year High Following Analyst Upgrade - MarketBeat
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic? - Finviz
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA and KEYTRUDA QLEX Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+ - Finviz
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA® and KEYTRUDA QLEX™ Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+ - Yahoo Finance
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Metis Global Partners LLC - MarketBeat
Mraz Amerine & Associates Inc. Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. - MarketBeat
MRK Stock Price, Forecast & Analysis | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Insider Sell Alert: Chirfi Guindo Sells 10,000 Shares of Merck & Co Inc (MRK) - GuruFocus
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co - MarketBeat
Merck: Keytruda Remains Resilient Despite LOE RisksBuy Upon Correction (NYSE:MRK) - Seeking Alpha
LSV Asset Management Has $444.77 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
0.88%
大文字化:
|
ボリューム (24 時間):